Modalis Therapeutics Corporation

4883・Growth Market・Pharmaceuticals

Official website

Modalis Therapeutics Corporation

4883・Growth Market・Pharmaceuticals

Official website

Modalis Therapeutics Corporation4883

Reference Indicators

Market Cap

30¥100M

P/E (Forecast)

—

P/B

1.0x

Dividend Yield (Forecast)

0.00%

ROE

-78.5%

EV/EBITDA

—

Financial Summary

Unit: ¥M

Item	2021Dec 2021	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Dec 2025
Net Sales	1	40	—	—	—
SG&A Expenses	231	241	267	245	231
Operating Income	-1,239	-2,063	-2,370	-1,337	-2,211
Non-operating Income	12	76	39	64	81
Non-operating Expenses	4	9	20	30	18
Ordinary Income	-1,231	-1,995	-2,351	-1,303	-2,148
Extraordinary Income	485	285	—	—	—
Extraordinary Losses	—	996	38	13	2
Pre-tax Income	-745	-2,707	-2,390	-1,316	-2,151
Income Taxes	-6	-4	1	0	1
Net Income	-738	-2,702	-2,391	-1,317	-2,152
EBITDA	-1,161	-1,939	-2,369	—	—
Operating Margin	-112676.7%	-5094.3%	—	—	—
ROA	-12.2%	-86.4%	-118.1%	-35.7%	-72.6%
ROE	-13.3%	-93.0%	-177.6%	-37.5%	-78.5%